5 Rising Stocks to Watch Now

Gilead Sciences Inc. (NASDAQ:GILD) delivered a profit and met Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share were the same at $0.50 in the quarter as EPS of $0.50 in the year-earlier quarter. Revenue Rose 10.48% to $2.66 billion from the year-earlier quarter.

Gilead Sciences Inc. reported adjusted EPS income of $0.50 per share. By that measure, the company met the mean analyst estimate of $0.50. It missed the average revenue estimate of $2.66 billion.

GILD

CryoLife Inc. (NYSE:CRY) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 33.33% to $0.08 in the quarter versus EPS of $0.12 in the year-earlier quarter. Revenue Rose 0.93% to $33.5 million from the year-earlier quarter.

CryoLife Inc. reported adjusted EPS income of $0.08 per share. By that measure, the company beat the mean analyst estimate of $0.07. It missed the average revenue estimate of $35.45 million.

CRY

Magellan Health Services Inc. (NASDAQ:MGLN) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 18.56% to $1.15 in the quarter versus EPS of $0.97 in the year-earlier quarter. Revenue Rose 4.62% to $842.7 million from the year-earlier quarter.

Magellan Health Services Inc. reported adjusted EPS income of $1.15 per share. By that measure, the company beat the mean analyst estimate of $1.01. It missed the average revenue estimate of $856.83 million.

MGLN

Nxstage Medical, Inc. (NASDAQ:NXTM) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.06 in the quarter versus EPS of $-0.09 in the year-earlier quarter. Revenue Rose 10.93% to $65.46 million from the year-earlier quarter.

Nxstage Medical, Inc. reported adjusted EPS loss of $0.06 per share. By that measure, the company beat the mean analyst estimate of $-0.07. It beat the average revenue estimate of $64.67 million.

NXTM

Medidata Solutions, Inc. (NASDAQ:MDSO) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 56.52% to $0.36 in the quarter versus EPS of $0.23 in the year-earlier quarter. Revenue Rose 27.21% to $68.07 million from the year-earlier quarter.

Medidata Solutions, Inc. reported adjusted EPS income of $0.36 per share. By that measure, the company beat the mean analyst estimate of $0.29. It beat the average revenue estimate of $66.67 million.

MDSO

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.